PTN
NASDAQ
$8.48
Palatin Technologies Inc (PTN)
Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Target: $53.50 (+530.90%)
Market Cap
$16M
Free Cash Flow Yield
-94.78%
Beta (5Y)
-0.09
Price Chart
Valuation
Market Cap$16M
Forward P/E42.92
PEG1.62
P/S1.22
P/B1.60
Profitability
Total Revenue (TTM)$13M
Gross Profit (TTM)$551K
EBITDA-$6.42M
Profit Margin-36.5%
Operating Margin-40.3%
EPS-$2.53
Financial Health
Free Cash Flow Yield-94.78%
Growth & Risk
FCF 5Y CAGR-5.79%
Beta (5Y)-0.09
Sharpe Ratio0.28